Internal Med

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sarris J et al. - Data supporting a safe and effective kava extract may encourage a re-introduction of kava to Europe, UK and Canada. This may provide a major socioeconomic benefit to Pacific Island nations, and to sufferers of anxiety disorders.

   

Related Articles

Additional evidence for the affective dimension of dyspnea in patients with COPD
Research in Nursing & Health, 11/24/09    Relevance Score: 46%

Anxiety and depressive disorders in offspring at high risk for anxiety: A meta-analysis
Journal of Anxiety Disorders, 11/19/09    Relevance Score: 46%

Relationships of Fear, Anxiety, and Depression With Physical Function in Patients With Knee Osteoarthritis
Archives of Physical Medicine and Rehabilitation, 11/06/09    Relevance Score: 46%

Prevalence, incidence, morbidity and treatment patterns in a cohort of patients diagnosed with anxiety in UK primary care
Family Practice, 11/04/09    Relevance Score: 46%

Anxiety Predicts Poor Perceived Health in Patients With an Implantable Defibrillator
Psychosomatics, 10/28/09    Relevance Score: 46%

Today in Complementary Medicine...keeping you current

Is the aronia berry the newest superfruit?
The Clinical Advisor, 12/04/09

Obstructive Sleep Apnea Management with Interactive Computer Technology and Nutrition: Two Case Reports
Journal of Alternative and Complementary Medicine, 12/04/09

Some Factors Predict Successful Short-Term Outcomes in Individuals With Shoulder Pain Receiving Cervicothoracic Manipulation: A Single-Arm Trial
Physical Therapy, 12/04/09